We are live on !
Find out more
UBS Portfolio holdings
AUM
$136B
Turnover
18.95%
1-Year Est. Return
16.36%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+16.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136B
AUM Growth
+$7.83B
(+6.1%)
Cap. Flow
+$3.56B
Cap. Flow % of AUM
Cap. Flow %
2.62%
Top 10 Holdings %
Top 10 Hldgs %
13.26%
Holding
11,505
New
1,064
Increased
4,754
Reduced
3,910
Closed
1,116
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
0.9
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$387M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$346M |
| 3 |
Crown Castle
CCI
|
+$229M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$218M |
| 5 |
Toronto Dominion Bank
TD
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
APA Corp
APA
|
+$473M |
| 3 |
FDO
FAMILY DOLLAR STORES
FDO
|
+$453M |
| 4 |
Herc Holdings
HRI
|
+$322M |
| 5 |
PETM
PETSMART INC
PETM
|
+$311M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.72% |
| 2 | Energy | 9.22% |
| 3 | Financials | 6.8% |
| 4 | Healthcare | 6.74% |
| 5 | Technology | 6.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
10101
CALL
Travere Therapeutics
TVTX
$4.72B
| $1K | ﹤0.01% |
100
-3,700
| -97% | -$43.5K |
2014 Q2
1 quarter
|
|
10102
CALL
United States Antimony
UAMY
$458M
| $1K | ﹤0.01% |
500
| – | – |
2014 Q2
1 quarter
|
|
10103
PUT
Big Sky Industrial
BSIN
$81.4M
| $1K | ﹤0.01% |
+7
| New | +$1.66K |
2014 Q3
0 quarters
|
|
10104
PUT
VEON
VEON
$5.72B
| $1K | ﹤0.01% |
4
-4
| -50% | -$841 |
2013 Q4
3 quarters
|
|
10105
Wheeler Real Estate Investment Trust
WHLR
$203K
| – | – |
0
| – | – |
2014 Q3
0 quarters
|
|
10106
Willamette Valley Vineyards
WVVI
$9.46M
| $1K | ﹤0.01% |
100
| – | – |
2013 Q3
4 quarters
|
|
10107
PUT
Westwater Resources
WWR
$53.2M
| – | – |
-2
| Closed | -$3.24K | – |
|
10108
DELISTED
Village Bank and Trust Financial Corp.
VBFC
| $1K | ﹤0.01% |
37
-151
| -80% | -$3.66K |
2013 Q4
3 quarters
|
|
10109
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $1K | ﹤0.01% |
1
-10
| -91% | -$7.46K |
2014 Q1
2 quarters
|
|
10110
CALL
DELISTED
Biolase, Inc.
BIOL
| – | – |
0
| – | – |
2014 Q3
0 quarters
|
|
10111
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1K | ﹤0.01% |
+40
| New | +$1.24K |
2014 Q3
0 quarters
|
|
|
ACGN
10112
PUT
DELISTED
Aceragen Inc
ACGN
| $1K | ﹤0.01% |
4
| – | – |
2014 Q2
1 quarter
|
|
|
SPPI
10113
CALL
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1K | ﹤0.01% |
100
-200
| -67% | -$1.56K |
2013 Q2
5 quarters
|
|
10114
DELISTED
Ambac Financial Group
AMBC.WS
| $1K | ﹤0.01% |
102
-1,302
| -93% | -$19.1K |
2013 Q2
5 quarters
|
|
|
AHPI
10115
DELISTED
Allied Healthcare Products
AHPI
| $1K | ﹤0.01% |
223
-280
| -56% | -$1.2K |
2013 Q2
5 quarters
|
|
|
RBCN
10116
PUT
DELISTED
Rubicon Technology, Inc.
RBCN
| $1K | ﹤0.01% |
+30
| New | +$2.05K |
2014 Q3
0 quarters
|
|
|
GPL
10117
DELISTED
Great Panther Mining Limited
GPL
| $1K | ﹤0.01% |
60
-300
| -83% | -$3.63K |
2013 Q4
3 quarters
|
|
|
MBII
10118
PUT
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $1K | ﹤0.01% |
+200
| New | +$1.34K |
2014 Q3
0 quarters
|
|
|
SBM
10119
DELISTED
ProShares Short Basic Materials
SBM
| $1K | ﹤0.01% |
6
-180
| -97% | -$22.3K |
2013 Q3
4 quarters
|
|
|
GNMK
10120
CALL
DELISTED
GenMark Diagnostics, Inc
GNMK
| $1K | ﹤0.01% |
+100
| New | +$1.08K |
2014 Q3
0 quarters
|
|
|
GNMK
10121
PUT
DELISTED
GenMark Diagnostics, Inc
GNMK
| $1K | ﹤0.01% |
+100
| New | +$1.08K |
2014 Q3
0 quarters
|
|
|
AMAG
10122
DELISTED
AMAG Pharmaceuticals
AMAG
| $1K | ﹤0.01% |
32
-2,914
| -99% | -$62.1K |
2013 Q2
5 quarters
|
|
|
ZN
10123
CALL
DELISTED
Zion Oil & Gas, Inc.
ZN
| $1K | ﹤0.01% |
500
-4,200
| -89% | -$7.91K |
2014 Q2
1 quarter
|
|
|
ENT
10124
PUT
DELISTED
Global Eagle Entertainment Inc.
ENT
| $1K | ﹤0.01% |
+4
| New | +$1.16K |
2014 Q3
0 quarters
|
|
|
ECT
10125
PUT
DELISTED
ECA Marcellus Trust 1 Interest
ECT
| $1K | ﹤0.01% |
100
| – | – |
2013 Q2
5 quarters
|
|
Similar funds
MGC
UBS's Q3 2014 Portfolio in Review
As of Q3 2014, UBS held 11,505 positions worth $136B, up 6.1% from $128B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS's Q3 2014 filing shows 1,064 new, 4,754 increased, 3,910 reduced and 1,116 closed positions. Its largest new stake was Alibaba: 1,105,926 shares worth $98.3M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 47% a quarter earlier, followed by Energy and Financials.
- UBS's largest Q3 2014 buy was Alibaba: 1,105,926 shares worth $98.3M.
- UBS added most to Amgen in Q3 2014, an estimated $387M increase.
- UBS's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- UBS fully exited SUSSER HOLDINGS CORPORATION COMMON STOCK in Q3 2014, selling an estimated $81.1M.
- UBS's ten largest holdings make up 13% of its $136B portfolio in Q3 2014.
- UBS opened 1,064 new positions and closed 1,116 in Q3 2014.
- UBS's portfolio value rose 6.1% quarter-over-quarter to $136B.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.